Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Gross Profit (2020 - 2025)

Historic Gross Profit for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $6.3 million.

  • KORU Medical Systems' Gross Profit rose 2079.8% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.3 million, marking a year-over-year increase of 2114.19%. This contributed to the annual value of $21.3 million for FY2024, which is 2767.24% up from last year.
  • According to the latest figures from Q3 2025, KORU Medical Systems' Gross Profit is $6.3 million, which was up 2079.8% from $6.5 million recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Gross Profit registered a high of $6.5 million during Q2 2025, and its lowest value of $3.2 million during Q2 2021.
  • Over the past 5 years, KORU Medical Systems' median Gross Profit value was $4.3 million (recorded in 2022), while the average stood at $4.5 million.
  • Within the past 5 years, the most significant YoY rise in KORU Medical Systems' Gross Profit was 6679.73% (2021), while the steepest drop was 3461.79% (2021).
  • KORU Medical Systems' Gross Profit (Quarter) stood at $3.8 million in 2021, then rose by 6.43% to $4.1 million in 2022, then grew by 6.2% to $4.3 million in 2023, then grew by 28.44% to $5.6 million in 2024, then increased by 12.62% to $6.3 million in 2025.
  • Its Gross Profit stands at $6.3 million for Q3 2025, versus $6.5 million for Q2 2025 and $6.0 million for Q1 2025.